Back
Cullen/Frost Bankers Vs. Keros Therapeutics Industry Stock Comparison
Sell
36
CFR
Cullen/Frost Bankers
Last Price:
111.18
Seasonality Move:
-1.78%
Buy
62
KROS
Keros Therapeutics
Last Price:
56.44
Seasonality Move:
54.08%
Sell
36
Cullen/Frost Bankers (CFR)
is a Sell
Is Cullen/Frost Bankers a Buy, Sell or Hold?
- The current Cullen/Frost Bankers [CFR] share price is $111.73. The Score for CFR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- CFR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Keros Therapeutics (KROS)
is a Buy
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $56.92. The Score for KROS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KROS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CFR Stock Price Chart
What is Cullen/Frost Bankers's stock price today?
-
The Cullen/Frost Bankers share price today is $111.73
The current trend is moderately bullish and CFR is experiencing slight buying pressure.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $56.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
CFR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.81 | Buy |
Relative Strength Index (14 RSI): | 53.24 | Buy |
Chaikin Money Flow: | 43643 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (108.25 - 113.13) | Buy |
Bollinger Bands (100): | (100.37 - 112.37) | Buy |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.17 | Buy |
Relative Strength Index (14 RSI): | 64.2 | Buy |
Chaikin Money Flow: | -162874 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.46 - 56.8) | Buy |
Bollinger Bands (100): | (45.02 - 53.82) | Buy |
CFR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 112.51 | Sell |
20-day SMA: | 110.6 | Buy |
50-day SMA: | 110.84 | Buy |
200-day SMA: | 106.96 | Buy |
8-day EMA: | 111.79 | Sell |
20-day EMA: | 110.94 | Buy |
50-day EMA: | 109.55 | Buy |
200-day EMA: | 107 | Buy |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55.92 | Buy |
20-day SMA: | 53.86 | Buy |
50-day SMA: | 50.03 | Buy |
200-day SMA: | 52.7 | Buy |
8-day EMA: | 55.87 | Buy |
20-day EMA: | 53.93 | Buy |
50-day EMA: | 51.33 | Buy |
200-day EMA: | 49.85 | Buy |
Cullen/Frost Bankers Earnings Growth & CFR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.93 per share, and a decrease next year of $0.09 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.30 per share, and a decrease next year of $0.44 per share.
Cullen/Frost Bankers Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |